12 Best ARK Stocks To Invest In
As technology and growth stocks surged during the pandemic, ARK Investment Management and Cathie Wood became two of retail investors' favorites over the previous year.
Crispr Therapeutics Ag (CRSP)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 7,776,119 | $1,258,876 | -7% | 2.34% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 904,800 | $146,478 | -12% | 0.38% |
| 3. | OrbiMed Advisors Samuel Isaly | 519,000 | $84,021 | -7% | 0.84% |
| 4. | 459,900 | $74,453 | +27% | 0.01% | |
| 5. | 391,100 | $63,315 | +12% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.95 | 27,461 | Large Shareholder | 5,380,940 | 2018-12-27 | Filing | |
| $24.89 | 12,737 | Large Shareholder | 5,353,479 | 2018-12-26 | Filing | |
| $24.97 | 53,655 | Large Shareholder | 5,340,742 | 2018-12-24 | Filing | |
| $23.18 | 11,742 | Large Shareholder | 5,287,087 | 2018-12-24 | Filing | |
| $22.91 | 2,603 | Large Shareholder | 5,275,345 | 2018-12-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $139.46 | 5,989 | Officer | 1,891 | 2021-08-06 | Filing | |
| $138.22 | 19,011 | Officer | 7,880 | 2021-08-06 | Filing | |
| $130.51 | 2,482 | Officer, Director | 187,719 | 2021-08-05 | Filing | |
| $129.82 | 6,819 | Officer, Director | 190,201 | 2021-08-05 | Filing | |
| $128.85 | 13,499 | Officer, Director | 197,020 | 2021-08-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 117,213 | $18,975,612 | 0% | |
| 2. | 22,900 | $3,707,281 | 0.02% | |
| 3. | 14,506 | $2,348,376 | 0.01% | |
| 4. | 12,200 | $1,975,000 | 0.02% | |
| 5. | 7,662 | $1,324,745 | 0.12% |
News See All
Hedge Funds Aren’t Crazy About CRISPR Therapeutics AG (CRSP) Anymore
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund and Insider Trading News: Brevan Howard Asset Management, Elliott Management, Canyon Capital Partners, Vizsla Resources (VIZSF), and More
Brevan Howard Asset Management has stopped accepting new cash into its two biggest multi-manager funds after the firm’s record year of performance swelled the money pools.
5 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best pharmaceutical stocks to buy according to Cathie Wood.
10 Best Biotech Stocks to Buy According to Cathie Wood
In this article we will take a look at the 10 best biotech stocks to buy according to Cathie Wood.
5 Best Biotech Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best biotech stocks to buy according to Cathie Wood.
10 Best Stocks to Buy in 2021 According to Cathie Wood
In this article we will take a look at the 10 best stocks to buy in 2021 according to Cathie Wood.
Is CRSP Stock A Buy or Sell?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors are starting to get cautious...
Cathie Wood’s Top 5 Stock Picks and ARK Portfolio Updates
In this article we will take a look at some of the top stocks picks of Cathie Wood from the sectors she is bullish on.
Cathie Wood’s Strong Comeback: ARK’s Latest Stock Picks, Portfolio Updates and Comments
In this article, we will analyze a video of Cathie Wood and see her important comments about various sectors, stocks and her expectations from the market.
Billionaire Hedge Funds
